The University of Chicago Header Logo

Connection

Rifat Hasina to Drug Synergism

Back to Details
This is a "connection" page, showing publications Rifat Hasina has written about Drug Synergism.
Rifat Hasina
Connection Strength
0.054
Drug Synergism
  1. MET and PI3K/mTOR as a potential combinatorial therapeutic target in malignant pleural mesothelioma. PLoS One. 2014; 9(9):e105919.
    View in: PubMed
    Score: 0.028
  2. The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target. PLoS One. 2013; 8(7):e67668.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.